JNJ
51
12
BAC
54
4
HAL
46
2
MS
64
2
HD
40
2
AMAT
48
4
GM
47
3
OMC
37
2
COST
51
-3
CNX
48
2
MDT
73
9
HCP
64
2
GILD
41
3
CSX
36
3
APH
55
5
SYF
71
7
EL
31
-2
QRVO
32
2
TRIP
67
7
GOOG
63
2
JNJ
51
12
BAC
54
4
HAL
46
2
MS
64
2
HD
40
2
AMAT
48
4
GM
47
3
OMC
37
2
COST
51
-3
CNX
48
2
MDT
73
9
HCP
64
2
GILD
41
3
CSX
36
3
APH
55
5
SYF
71
7
EL
31
-2
QRVO
32
2
TRIP
67
7
GOOG
63
2
Financhill
Back

First Resources Vs. SpringWorks Therapeutics Industry Stock Comparison

Buy
83

FTROF
First Resources

Last Price:
$1.23
Seasonality Move:
0%
Sell
9

SWTX
SpringWorks Therapeutics

Last Price:
$32.50
Seasonality Move:
-2.03%
Buy
83
First Resources (FTROF) is a Buy

Is First Resources a Buy, Sell or Hold?

  • The current First Resources [FTROF] share price is $1.23. The Score for FTROF is 83, which is 66% above its historic median score of 50, and infers lower risk than normal.
  • FTROF is currently trading in the 80-90% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk levels may be considerably lower than normal.
Sell
9
SpringWorks Therapeutics (SWTX) is a Sell

Is SpringWorks Therapeutics a Buy, Sell or Hold?

  • The current SpringWorks Therapeutics [SWTX] share price is $32.50. The Score for SWTX is 9, which is 82% below its historic median score of 50, and infers higher risk than normal.
  • SWTX is currently trading in the 0-10% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk could be especially high.

FTROF Stock Price Chart

What is First Resources's stock price today?

  • The First Resources share price today is $1.23
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and FTROF is experiencing slight buying pressure.

SWTX Stock Price Chart

What is SpringWorks Therapeutics's stock price today?

  • The SpringWorks Therapeutics share price today is $32.50
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SWTX is experiencing selling pressure, which indicates risk of future bearish movement.

FTROF Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.03 Buy
Relative Strength Index (14 RSI): 82.61 Buy
Chaikin Money Flow: 0 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (0.53 - 1.01) Buy
Bollinger Bands (100): (0.84 - 1.24) Buy

SWTX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.02 Sell
Relative Strength Index (14 RSI): 37.1 Sell
Chaikin Money Flow: -2546118 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (35.59 - 40.53) Sell
Bollinger Bands (100): (31.91 - 40.11) Sell

FTROF Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 0.86 Buy
20-day SMA: 0.73 Buy
50-day SMA: 0.96 Buy
200-day SMA: 1.07 Buy
8-day EMA: 0.95 Buy
20-day EMA: 0.85 Buy
50-day EMA: 0.91 Buy
200-day EMA: 0.06 Buy

SWTX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 38.42 Sell
20-day SMA: 37.4 Sell
50-day SMA: 37.33 Sell
200-day SMA: 38.27 Sell
8-day EMA: 37.61 Sell
20-day EMA: 37.86 Sell
50-day EMA: 37.24 Sell
200-day EMA: 37 Sell

First Resources Earnings Growth & FTROF Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

SpringWorks Therapeutics Earnings Growth & SWTX Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.37 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.12 per share, and an increase next year of $1.33 per share.

First Resources Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

SpringWorks Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):